Delivery Order SPE2DB24D3013-SPE2DB26FFGCT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,307.00 to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion (60 single-use containers) on August 11, 2025, with an ultimate completion date of August 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's larger prime contract vehicle. The pharmaceutical will be delivered to the company's distribution facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $8,041.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion (60 count). This is a non-set-aside competitive award with an ultimate completion date of September 18, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in Conshohocken, PA. This...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 28, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 30-unit quantities. This non-set-aside, firm fixed-price delivery order carries a ceiling value of $1,045.92 and is scheduled for ultimate completion by May 29, 2025. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $2,947.68 to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion in 30-count packages. The contract is a firm fixed price delivery order with an ultimate completion date of September 22, 2025, and was awarded on September 19, 2025. This award carries no set-aside designation, indicating it was competitively awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion in 30-count units, valued at $3,474.29, with an ultimate completion date of October 31, 2025. This firm fixed-price delivery order carries no set-aside designation and was competitively awarded. The product will be performed at the awardee's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $20,448.66 to AmerisourceBergen Drug Corp for the supply of Cyclosporine 0.05% Eye Emulsion (30-count units) on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The contract represents a child order under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $2,036.72 to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion (30 count) under a firm fixed price contract. The award was issued on November 4, 2025, with an ultimate completion date of November 5, 2025, and represents a non-set-aside competitive procurement. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued against AmerisourceBergen...
- The Defense Logistics Agency awarded a $1,342.35 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion (30-count units). This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract specifies a place of performance in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters, with an ultimate completion date of July 25, 2025. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $7,893.61 to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Cyclosporine 0.05% eye emulsion in 30-count units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 23, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's existing contract vehicle...
- The Defense Logistics Agency awarded a $23,086.01 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Cyclosporine 0.05% eye emulsion in 60-unit quantities. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of September 2, 2025. This delivery order is issued under AmerisourceBergen's...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB26FFGCTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,522.35 to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion (60 units) on November 4, 2025, with an ultimate completion date of November 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its comprehensive IDC vehicle, which enables the supply of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare systems worldwide. The company's portfolio of federal contract awards demonstrates extensive experience fulfilling diverse pharmaceutical needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. This delivery order for Cyclosporine, an immunosuppressant eye medication, exemplifies the company's role in supplying specialized pharmaceutical products to support military and federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/4/25 |